# Cancer Genetics and Metabolism Program

> **NIH NIH P30** · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2021 · $38,066

## Abstract

The primary goal of the Cancer Genetics and Metabolism (CGM) Program is to support the clinical,
translational, and basic research missions of the Wake Forest Baptist Comprehensive Cancer Center
(WFBCCC) related to two fundamental hallmarks of cancer: genetic alterations and metabolic reprogramming.
There are numerous unmet needs in these areas for extensive research in mechanism, clinical association,
and therapeutic opportunities. Members of the CGM Program synergize their efforts to carry out well-rounded
research projects organized in two specific aims: 1) to understand the deregulated cancer genome and its
implications in prognostics and therapeutics; and 2) to interrogate cancer metabolic alterations and develop
novel therapeutic approaches. The ultimate goal is the greater understanding of the interactions between both
hallmarks to improve the lives of patients with cancer.

## Key facts

- **NIH application ID:** 10093005
- **Project number:** 5P30CA012197-46
- **Recipient organization:** WAKE FOREST UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Wei Zhang
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $38,066
- **Award type:** 5
- **Project period:** 1997-02-01 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10093005

## Citation

> US National Institutes of Health, RePORTER application 10093005, Cancer Genetics and Metabolism Program (5P30CA012197-46). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10093005. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*